Go Pro
NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Aveanna Healthcare logo
$14.08 +0.22 (+1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$14.03 -0.05 (-0.33%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Advanced

Key Stats

Today's Range
$13.88
$14.54
50-Day Range
$8.95
$14.08
52-Week Range
$5.93
$14.54
Volume
2.37 million shs
Average Volume
3.61 million shs
Market Capitalization
$3.07 billion
P/E Ratio
11.45
Dividend Yield
N/A
Price Target
$13.50
Consensus Rating
Moderate Buy

Company Overview

Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.

Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy. Through these offerings, the company supports patients with skilled nursing needs, rehabilitation requirements, chronic illnesses and end-of-life care.

Headquartered in Atlanta, Georgia, Aveanna serves patients across a broad network of states in the U.S. The company was formed through the combination of healthcare businesses including Epic Health Services and PSA Healthcare and became a publicly traded company on the Nasdaq under the symbol AVAH in 2021. Aveanna is led by Chief Executive Officer Jeff Shaner.

AI Generated. May Contain Errors.

Aveanna Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

AVAH MarketRank™: 

Aveanna Healthcare scored higher than 75% of companies evaluated by MarketBeat, and ranked 174th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aveanna Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 6 buy ratings, 5 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Aveanna Healthcare is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Aveanna Healthcare has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Aveanna Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Aveanna Healthcare are expected to grow by 12.00% in the coming year, from $0.75 to $0.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aveanna Healthcare is 11.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.09.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aveanna Healthcare is 11.45, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.69.

  • Price to Earnings Growth Ratio

    Aveanna Healthcare has a PEG Ratio of 0.87. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Aveanna Healthcare has a P/B Ratio of 15.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Aveanna Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    2.66% of the float of Aveanna Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Aveanna Healthcare has a short interest ratio ("days to cover") of 1.39, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aveanna Healthcare has recently increased by 2.67%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Aveanna Healthcare does not currently pay a dividend.

  • Dividend Growth

    Aveanna Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Aveanna Healthcare has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Aveanna Healthcare this week, compared to 6 articles on an average week.
  • Search Interest

    Only 19 people have searched for AVAH on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -77% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $649,301,514.00 in company stock.

  • Percentage Held by Insiders

    5.30% of the stock of Aveanna Healthcare is held by insiders.

  • Percentage Held by Institutions

    87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aveanna Healthcare's insider trading history.
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVAH Stock News Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Headlines

AVAH Stock Analysis - Frequently Asked Questions

Aveanna Healthcare's stock was trading at $8.17 on January 1st, 2026. Since then, AVAH stock has increased by 72.3% and is now trading at $14.08.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its quarterly earnings data on Thursday, August, 13th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.05. The company had revenue of $670.48 million for the quarter, compared to analysts' expectations of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a trailing twelve-month return on equity of 80.70%.
Read the conference call transcript
.

Aveanna Healthcare (AVAH) raised $478 million in an IPO on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Aveanna Healthcare's top institutional investors include BlackRock Inc. (3.40%), Braidwell LP (1.40%), Algert Global LLC (0.74%) and Connor Clark & Lunn Investment Management Ltd. (0.42%). Insiders that own company stock include Robert M Williams Jr, Paul R Vigano, JH Whitney Equity Partners V, Jeff Shaner, Rodney D Windley, Edwin C Reisz, Matthew Buckhalter, Deborah Stewart and Patrick A Cunningham.
View institutional ownership trends
.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/13/2026
Today
9/11/2026
2026 Jefferies Healthcare Services and Technology Conference
9/15/2026
Deutsche Bank 2026 Healthcare Summit
9/16/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:AVAH
CIK
1832332
Fax
N/A
Employees
35,500
Year Founded
2017

Price Target and Rating

High Price Target
$16.00
Low Price Target
$10.00
Potential Upside/Downside
-4.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.23
Trailing P/E Ratio
11.45
Forward P/E Ratio
18.77
P/E Growth
0.87
Net Income
$225.03 million
Net Margins
10.56%
Pretax Margin
5.92%
Return on Equity
80.70%
Return on Assets
7.42%

Debt

Debt-to-Equity Ratio
4.47
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$2.43 billion
Price / Sales
1.26
Cash Flow
$0.70 per share
Price / Cash Flow
20.10
Book Value
$0.93 per share
Price / Book
15.14

Miscellaneous

Outstanding Shares
218,220,000
Free Float
206,654,000
Market Cap
$3.07 billion
Optionable
Optionable
Beta
1.97

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:AVAH) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners